다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Yumanity Therapeutics Inc (YMTX)
Yumanity Therapeutics Inc (YMTX) 뉴스

YMTX

Yumanity Therapeutics (YMTX)

Yumanity Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:YMTX

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/12/17	04:58	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/17	00:38	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/15	20:43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/14	06:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/07	06:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/07	06:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/07	06:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/07	06:05	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/07	06:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/05	23:29	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/05	23:28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/05	21:30	GlobeNewswire Inc.	Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/12/02	06:05	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/16	06:04	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/16	06:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/14	22:45	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/14	22:38	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/14	22:16	GlobeNewswire Inc.	Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/14	20:09	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/11	06:27	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/11	06:15	GlobeNewswire Inc.	Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/11/05	05:53	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/27	20:16	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/27	20:14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/27	06:19	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/27	06:18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/27	06:09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/24	22:17	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/24	21:02	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:YMTX	Yumanity Therapeutics Inc
2022/10/24	20:59	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:YMTX	Yumanity Therapeutics Inc

검색 관련기사 보기:NASDAQ:YMTX

1 2 3 4 5 6 다음 >>

Invesco QQQ Trust Series 1

Financial Select Sector

American Express

Gold vs US Dollar

Deutsche Telekom (QX)

BNP Paribas (QX)

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관